# L'OREAL USA, INC. – FDA Inspection, Jun 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/loreal-usa-inc/5115d1e2-2f2c-4160-8869-a8eb6599a6a2
Source feed: FDA_Inspections

> FDA inspection 1172731 of L'OREAL USA, INC., June 24, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172731
- Company Name: L'OREAL USA, INC.
- Inspection Date: 2022-06-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 989523 - 2016-08-12](https://www.keypedia.com/records/fda_inspections/loreal-usa-inc/cd2f8b64-cb86-492d-8ab3-aea9e6334ffa)
- FDA Inspection 805325 - 2012-10-30
- [FDA Inspection 634549 - 2009-12-14](https://www.keypedia.com/records/fda_inspections/loreal-usa-inc/b8d31189-3270-4e4d-a6a0-47a7391c9166)

Company: https://www.keypedia.com/companies/loreal-usa-inc/7d3b71d5-dca8-478c-ac59-221294019eda

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c